Profile
Shamel Costandy worked as the Chief Financial Officer at Divergent Energy Services Corp.
from 2008 to 2010.
He also worked as a Financial Controller at Trillium Therapeutics ULC.
Former positions of Shamel Costandy
| Companies | Position | End |
|---|---|---|
| DIVERGENT ENERGY SERVICES CORP. | Director of Finance/CFO | 2010-12-07 |
| TRILLIUM THERAPEUTICS | Comptroller/Controller/Auditor | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DIVERGENT ENERGY SERVICES CORP. | Industrial Services |
| Private companies | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Shamel Costandy
